Finlight

2021-09-04 09:54:34 Dr. Reddy's Laboratories enters into definitive agreement with Citius Pharmaceuticals, Inc. to sell its rights to anti-cancer agent E7777 (denileukin diftitox)

Under the terms of agreement, Dr. Reddy's will receive $40 million upfront upon the closing of the transaction, followed by approval milestone payment of up to $40 million related to the CTCL (cutaneous T- cell lymphoma) indication approval and up to $70 million for additional indication approvals. Further, Dr. Reddy's will receive certain sales-based milestones and tiered earn-out payments. Open / Comment

2021-09-04 09:53:45 Open / Comment

2021-09-03 20:27:01 Open / Comment

2021-09-03 20:26:47 HCG Acquires Oncology Labs & Divested stake In Strand Lifesciences to Reliance

Will Focus on integrated & Specialised Diagnostic Scale Up Open / Comment

2021-09-03 20:02:45 Govt Sources To CNBC-TV18: "No decision has been taken as yet. Matter is still under consideration
Premature speculation may please be avoided" Open / Comment

2021-09-03 20:02:13 HFCL board approves plan to raise Rs 750 crore through various issues Open / Comment

2021-09-03 18:44:10 Open / Comment

2021-09-03 18:27:49 BINNARI AMMAN SPINING MILLS : Co. approved Rights issue aggregating to Rs 100 CR , Rs 30/share Open / Comment

2021-09-03 18:10:43 J&K BANK : RBI Has accorded approval to govt. of J&K To acquire 16.8 cr paid up equity shares on preferential basis i.e upto 74.2 % of post issue paid up voting equity capital of the bank Open / Comment

2021-09-03 18:10:19 GOKALDAS EXPORTS : Co. commenced production at New manufacturing unit at Tumkur Open / Comment